Detection of Disseminated Tumor Cells in Neuroblastoma-Reference-Cited by-同舟云学术

Detection of Disseminated Tumor Cells in Neuroblastoma

Published:2003-08 Issue:2 Volume:163 Page:393-399
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Méhes Gabor,Luegmayr Andrea,Kornmüller Rosa,Ambros Ingeborg M.,Ladenstein Ruth,Gadner Helmut,Ambros Peter F.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference31 articles.

1. Unequivocal identification of disseminated tumor cells in the bone marrow by combining immunological and genetic approaches: functional and prognostic information;Ambros;Leukemia,2001

2. Combined automatic immunological and molecular cytogenetic analysis allows exact identification and quantification of tumor cells in the bone marrow;Mehes;Clin Cancer Res,2001

3. Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution;Hartmann;Bone Marrow Transplant,1999

4. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of 1 year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry;Ladenstein;J Clin Oncol,1998

5. Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group study;Seeger;J Clin Oncol,2000

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse;Journal of Clinical Medicine;2023-09-25

2. Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial;Journal of Clinical Oncology;2023-06-10

3. Comparison of three different methods to detect bone marrow involvement in patients with neuroblastoma;Journal of Cancer Research and Clinical Oncology;2021-10-08

4. Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma;British Journal of Cancer;2021-09-01

5. Landscape of Bone Marrow Metastasis in Human Neuroblastoma Unraveled by Transcriptomics and Deep Multiplex Imaging;Cancers;2021-08-26